Wiggin and Dana

Subscribe to Wiggin and Dana's Posts

Senior Counsel Robert M. Langer and Michael A. Kurs of Pullman & Comley have co-authored an article titled, “The Federal Trade Commission and the U.S. DOJ Antitrust Division during the Biden Administration Have Significantly Ramped Up Antitrust Enforcement: Non-Antitrust Lawyers Beware!” in the Connecticut Bar Association’s Connecticut Lawyer Magazine.

The article discusses the efforts of the Federal Trade Commission and the Antitrust Division of the…

Read More The Federal Trade Commission and the U.S. DOJ Antitrust Division during the Biden Administration Have Significantly Ramped Up Antitrust Enforcement: Non-Antitrust Lawyers Beware!

As we continue in another year of growth, we want to assure you that we are here to provide timely, cost effective and thoughtful legal counsel to a diverse client base. Attached is our M&A practice year end review. We trust you will find it both interesting and a reflection of our expertise as we look forward to the year ahead.

To read more, please…

Read More 2022 M&A End Year Report

Wiggin and Dana is pleased to present its Intellectual Property Practice Group’s latest newsletter: “Recent Developments in IP Law.” This newsletter takes a look back at some of the biggest developments in intellectual property law in 2019, as well as a look forward at what we can expect for 2020.

To read the newsletter, please click the PDF link at the bottom of the page.…

Read More Recent Developments in Intellectual Property Law

Between suppliers and manufacturers, planning for the termination of a supply agreement during its negotiation may seem counterintuitive, awkward, or perhaps insignificant. Termination discussions often take a back seat in the conference room where the negotiating energy is spent primarily on price, quality, and delivery terms. As one court observed, termination is typically “of little interest or concern to the parties” so long as they…

Read More Termination for Convenience Under the Uniform Commercial Code

Connecticut recently awarded licenses to four medical marijuana producers, marking the beginning of Connecticut’s legal medical marijuana industry. Although medical marijuana businesses are licensed and heavily regulated by the State of Connecticut,[1] they have had difficulty securing basic financial services due to ambiguities in federal policy. Financial institutions are wary of servicing such clients owing to the requirements of the Bank Secrecy Act and…

Read More New Guidance on Providing Financial Services to Medical Marijuana Businesses

Upcoming revisions to the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”) will result in numerous additional pharmaceutical licensing transactions becoming subject to filing requirements under the HSR Act. On November 6, the U.S. Federal Trade Commission (the “FTC”) released the final version of amendments to be made to the HSR Act. The amendments will impact the analysis of whether parties to…

Read More Federal Trade Commission Expands Requirements for Reporting Pharmaceutical Patent License Transactions